Enrolling until December 31, 2025
The Department of Dermatology at the Mount Sinai School of Medicine in New York City is enrolling children and adults with alopecia areata (all types) in two studies. The investigational drugs are dupilumab and ritlecitinib.
Study #1 with dupilumab (Dupixent)
Investigational drug Dupixent (dupilumab) for ages 6 to adult.
Trial…
Continue